Weichang Zhou
Direktor/Vorstandsmitglied bei WUXI BIOLOGICS (CAYMAN) INC.
Vermögen: 434 164 $ am 30.04.2024
Profil
Derzeit bekleidet Weichang Zhou die Position des Executive Director, Chief Technology Officer & EVP bei Wuxi Biologics (Cayman), Inc. Zuvor hatte er die Position eines Associate Director bei Merck & Co. inne. Dr. Zhou erhielt einen Bachelor-Abschluss von der Jiangxi University of Science & Technology und einen Doktortitel von der Universität Hannover.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.03.2024 | 247 139 ( 0,01% ) | 434 164 $ | 30.04.2024 |
Aktive Positionen von Weichang Zhou
| Unternehmen | Position | Beginn |
|---|---|---|
| WUXI BIOLOGICS (CAYMAN) INC. | Direktor/Vorstandsmitglied | 01.05.2016 |
| WUXI XDC CAYMAN INC. | Direktor/Vorstandsmitglied | 01.12.2020 |
Ehemalige bekannte Positionen von Weichang Zhou
| Unternehmen | Position | Ende |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 01.12.2012 |
| PDL BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 01.02.2008 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01.10.2002 |
Ausbildung von Weichang Zhou
| Jiangxi University of Science & Technology | Undergraduate Degree |
| University of Hannover | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| WUXI XDC CAYMAN INC. | Commercial Services |
| Private Unternehmen | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
